mizoribine has been researched along with Sjogren's Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imadachi, S; Ito, M; Iwanaga, N; Izumi, Y; Kamata, M; Kurohama, H; Migita, K; Nakaoka, K | 1 |
| Fujimoto, T; Nakamura, S; Nakayamada, S; Nonomura, A; Saito, K; Tanaka, Y | 1 |
| Abe, T; Imai, K; Kimura, H; Matsumoto, S; Nishimura, S; Nojima, M; Oki, M; Sakai, H; Taga, M; Takahashi, H; Tanaka, H | 1 |
| Iizuka, N; Kondo, H | 1 |
| Hashimoto, N; Ito, S; Kondo, H; Mimori, T; Minota, S; Nakayamada, S; Nara, H; Ogawa, N; Okada, J; Saito, K; Sano, H; Sugai, S; Sumida, T; Tanaka, Y; Umehara, H; Yoshifuji, H | 1 |
2 review(s) available for mizoribine and Sjogren's Syndrome
| Article | Year |
|---|---|
[A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Therapy, Combination; Etodolac; Female; Humans; Hyperuricemia; Middle Aged; Phenylacetates; Prednisolone; Ribonucleosides; Sjogren's Syndrome | 2004 |
[Mizoribine].
Topics: Animals; Arthritis, Rheumatoid; Depression, Chemical; Guanosine Monophosphate; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Activation; Mice; Purines; Randomized Controlled Trials as Topic; Ribonucleosides; Sjogren's Syndrome; T-Lymphocytes | 2005 |
2 trial(s) available for mizoribine and Sjogren's Syndrome
| Article | Year |
|---|---|
Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Ribonucleosides; Salivary Glands, Minor; Salivation; Sjogren's Syndrome; Treatment Outcome | 2009 |
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.
Topics: Aged; Deglutition Disorders; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Ribonucleosides; Saliva; Salivation; Sjogren's Syndrome; Treatment Outcome; Xerophthalmia | 2007 |
1 other study(ies) available for mizoribine and Sjogren's Syndrome
| Article | Year |
|---|---|
Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren's syndrome successfully treated with mizoribine.
Topics: Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Prednisolone; Protein-Losing Enteropathies; Ribonucleosides; Sjogren's Syndrome | 2018 |